Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Inoue

Showing results (481-490 of 487) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 487 results.
Cancer Medicine|December 9, 2025
Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correlating With CortactinJunya Tsuboi, Akiko Eguchi, Hiroyuki Inoue, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1cShun-ichiro Asahara, Hiroaki Etoh, Hiroyuki Inoue, et al.
Iscience|December 22, 2021
Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environmentJunjiro Yoshida, Tomokazu Ohishi, Hikaru Abe, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2016
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumorsMutsunori Murahashi, Yasuki Hijikata, Kazunari Yamada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102)Yoshimasa Shiraishi, Takayuki Shimose, Motoko Tachihara, et al.
Journal of Gastric Cancer|April 6, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective StudyTakuma Ohashi, Takeshi Kubota, Hayato Fukui, et al.
Cytotherapy|July 24, 2023
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)Rishu Takimoto, Takashi Kamigaki, Hisao Ito, et al.
Pageof 49

Showing results (481-490 of 487) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 487 results.
Cancer Medicine|December 9, 2025
Plexin Domain Containing 2, a Protein Specifically Expressed and Elevated in Human Pancreatic Cancer Tissue and Serum, Influences Cell Proliferation by Correlating With CortactinJunya Tsuboi, Akiko Eguchi, Hiroyuki Inoue, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1cShun-ichiro Asahara, Hiroaki Etoh, Hiroyuki Inoue, et al.
Iscience|December 22, 2021
Mitochondrial complex I inhibitors suppress tumor growth through concomitant acidification of the intra- and extracellular environmentJunjiro Yoshida, Tomokazu Ohishi, Hikaru Abe, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2016
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumorsMutsunori Murahashi, Yasuki Hijikata, Kazunari Yamada, et al.
European Journal of Cancer (Oxford, England : 1990)|September 17, 2025
Atezolizumab with carboplatin plus nab-paclitaxel combination therapy for TTF-1 negative advanced nonsquamous non-small cell lung cancer: A multicenter, single-arm phase 2 trial (F1NE TUNE, LOGiK 2102)Yoshimasa Shiraishi, Takayuki Shimose, Motoko Tachihara, et al.
Journal of Gastric Cancer|April 6, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective StudyTakuma Ohashi, Takeshi Kubota, Hayato Fukui, et al.
Cytotherapy|July 24, 2023
Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)Rishu Takimoto, Takashi Kamigaki, Hisao Ito, et al.
Pageof 49